Trials / Recruiting
RecruitingNCT05907265
Immersive Virtual Reality Techniques on the Effects on Cognition in People With Cancer
Study of the Benefits of Immersive Virtual Reality Techniques on the Effects on Cognition in People With Cancer (OncoBRAIN)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Consorci Sanitari de Terrassa · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
OncoBRAIN aims to assess the effect of an innovative immersive virtual reality-based (IVR) intervention that includes cognitive, physical activity and mindfulness exercises in people diagnosed with cancer and Chemotherapy-Related Cognitive Deficits (CRCD). The main objective of OncoBRAIN is to determine the benefits of RVI intervention on the cognitive, and emotional state and quality of life of people with cancer and CRQD. We hypothesize that in OncoBRAIN we will find improvements in people with cancer and CRCD who have received IVR stimulation compared to the control group with cancer and CRCD who have not received IVR stimulation. People in the experimental group will perform better than patients in the control group in cognition (episodic memory, executive function, attention, and information processing speed), show better emotional well-being and perceive a better quality of life at the end of the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Behavioral: ONCOBrain_ImmersiveVR | A multimodal and digitally-based cognitive training, physical exercise and mindfulness intervention delivered face to face and through 360MK Virtual Reality technology |
| BEHAVIORAL | Behavioral: Control_Condition | Traditional paper or pdf format multimodal intervention that will combine cognitive, mediation and physical activities. |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2026-12-30
- Completion
- 2027-06-30
- First posted
- 2023-06-18
- Last updated
- 2026-04-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05907265. Inclusion in this directory is not an endorsement.